Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marc Kamin, MD
SK Life Science, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Oregon Health and Science University
Portland, Oregon, United States
- the University of Utah School of Medicine - Primary Children'S Hospital (primary Children'S Medical Center)
Salt Lake City, Utah, United States
- Uw Valley Medical Center
Renton, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 May 2019
- Primary completion
- 14 Dec 2022
- Completion
- 14 Dec 2022
- Last update posted
- 4 Apr 2024
- Registered enrollment
- 15
- Registry id
- NCT04062981
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.